Treace Medical Concepts, Inc.
TMCINASDAQHealthcareMedical Devices

About Treace Medical Concepts

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to correct three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible correction of metatarsus adductus deformities and osteoarthritis of the midfoot. It serves physicians, surgeons, ambulatory surgery centers and hospitals related to the surgical management of bunion and related midfoot deformities. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.

Company Information

CEOJohn Treace
Founded2014
IPO DateApril 23, 2021
Employees477
CountryUnited States
Fiscal YearJanuary - December

Stock Details

ExchangeNASDAQ (NASDAQ)
CurrencyUSD - USD
TypeStock
SubtypeCommon Stock

Contact Information

Phone904 373 5940
Address
100 Palmetto Park Place Ponte Vedra, Florida 32081 United States

Corporate Identifiers

CIK0001630627
CUSIP89455T109
ISINUS89455T1097
EIN47-1052611
SIC3841

Leadership Team & Key Executives

John T. Treace
Founder, Chairman and Chief Executive Officer
Mark L. Hair CPA
Chief Financial Officer
Scot M. Elder J.D.
Chief Legal and Compliance Officer and Corporate Secretary
Dr. Sean F. Scanlan Ph.D.
Chief Innovation Officer
Gaetano M. Guglielmino
Chief Commercial Officer
Terry W. Lubben
Chief Operations and Supply Chain Officer
Taylor Erickson
Chief Information and Cybersecurity Officer
Brad Barr
Senior Vice President of Sales
Daniel E. Owens
Chief Human Resources Officer
Shana Zink
Senior Vice President of Clinical Affairs and Reimbursement